MedPath

Effectiveness and Safety of Single-session Endoscopic Stone Extraction

Not Applicable
Recruiting
Conditions
Choledocholithiasis With Acute Cholangitis
Interventions
Procedure: single-session ERCP
Procedure: two-session ERCP
Registration Number
NCT06349954
Lead Sponsor
Beijing Friendship Hospital
Brief Summary

This is a prospective study, including approximately 64 patients with acute cholangitis accompanied with choledocholithiasis at Beijing Friendship Hospital. All patients will be randomly allocate into single-session or two-session endoscopic stone extraction. The investigators assessed the outcomes of single-session and two-session endoscopic stone extraction.

Detailed Description

Acute cholangitis is an acute inflammation caused by obstruction of the bile duct, of which choledocholithiasis is the most common cause. Without timely removal of the obstruction or control of the infection, cholangitis can get worse and even become life-threatening. Therefore, timely and effective treatment is essential for patients with acute cholangitis combined with choledocholithiasis. Endoscopic retrograde cholangiography (ERCP) is used as the first-line treatment for choledocholithiasis-associated acute cholangitis. Previous guidelines recommended two-session endoscopic therapy. Endoscopic biliary drainage as the initial treatment, followed by endoscopic stone extraction after cholangitis improved. In recent years, studies have found that single-session endoscopic stone extraction is safe and effective for patients without serious organ function impairment. Meanwhile, single-session endoscopic lithotomy can avoid the second ERCP intervention, which can relieve the pain of patients, reduce medical costs and shorten the length of hospital stay. However, there is still insufficient evidence on the effectiveness and safety of early single-session ERCP lithotomy. The aim of this study is to evaluate the efficacy and safety of single-session endoscopic stone extraction for acute cholangitis associated with choledocholithiasis, so as to provide reference of clinical treatment.

In a prospective study, approximately 64 patients with acute cholangitis accompanied with choledocholithiasis will be involved. The investigators assessed the outcomes of single-session and two-session endoscopic stone extraction.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria
    1. Age ≥18 years old and ≤90 years old
    1. Patients met the Tokyo Guidelines 2018 (TG18) diagnosis of Grade I or Grade II acute cholangitis
    1. Imaging examination confirmed the presence of choledocholithiasis
Exclusion Criteria
    1. Common bile duct with benign or malignant stenosis
    1. Changes in the anatomical structure of the stomach or duodenum
    1. Patients with common biliary duct or pancreatic duct stent
    1. Patients complicated with acute pancreatitis
    1. Patients who underwent endoscopic intervention, percutaneous transhepatic cholangio drainage (PTCD) or other invasive interventions before admission
    1. Patients with cardiac failure, respiratory failure or consciousness disorder can not tolerate endoscopic operation
    1. Patients who have coagulation dysfunction or are taking anticoagulation and antiplate drugs
    1. Imaging examination showed that the maximum diameter of choledocholithiasis was more than 1.5cm

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
single-session treatment groupsingle-session ERCPsingle-session ERCP
two-session treatment grouptwo-session ERCPtwo-session ERCP
Primary Outcome Measures
NameTimeMethod
Success rate of complete stone removalduring the operation

Segmental angiography was performed by balloon closure to determine the presence or absence of negative stone shadow

ERCP-related complication ratefrom the operation to 1 month after the operation

The complications include pancreatitis, hemorrhage, perforation, pneumonia, etc. The results of intraoperative endoscopic observation, postoperative symptoms and signs, blood routine examination, amylase, lipase, and imaging and endoscopic examination were measured.

Secondary Outcome Measures
NameTimeMethod
Length of stayperioperatively

Total time from admission to discharge.

Hospital expensesperioperatively

Total expenses from admission to discharge.

Trial Locations

Locations (1)

Beijing Friendship Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath